Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Therapeutic targets in myeloma bone disease.

Marino S, Petrusca DN, Roodman GD.

Br J Pharmacol. 2019 Oct 24. doi: 10.1111/bph.14889. [Epub ahead of print] Review.

PMID:
31647573
2.

Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis.

Petrusca DN, Toscani D, Wang FM, Park C, Crean CD, Anderson JL, Marino S, Mohammad KS, Zhou D, Silbermann R, Sun Q, Kurihara N, Galson DL, Giuliani N, Roodman GD.

J Hematol Oncol. 2018 Oct 4;11(1):123. doi: 10.1186/s13045-018-0666-5.

3.

Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism.

Rezania S, Puskarich MA, Petrusca DN, Neto-Neves EM, Rondina MT, Kline JA.

Thromb Res. 2017 Jul;155:106-115. doi: 10.1016/j.thromres.2017.05.009. Epub 2017 May 13.

PMID:
28528289
4.

Alpha-1 antitrypsin supplementation improves alveolar macrophages efferocytosis and phagocytosis following cigarette smoke exposure.

Serban KA, Petrusca DN, Mikosz A, Poirier C, Lockett AD, Saint L, Justice MJ, Twigg HL 3rd, Campos MA, Petrache I.

PLoS One. 2017 Apr 27;12(4):e0176073. doi: 10.1371/journal.pone.0176073. eCollection 2017.

5.

Structural and functional characterization of endothelial microparticles released by cigarette smoke.

Serban KA, Rezania S, Petrusca DN, Poirier C, Cao D, Justice MJ, Patel M, Tsvetkova I, Kamocki K, Mikosz A, Schweitzer KS, Jacobson S, Cardoso A, Carlesso N, Hubbard WC, Kechris K, Dragnea B, Berdyshev EV, McClintock J, Petrache I.

Sci Rep. 2016 Aug 17;6:31596. doi: 10.1038/srep31596.

6.

Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells.

Lockett AD, Petrusca DN, Justice MJ, Poirier C, Serban KA, Rush NI, Kamocka M, Predescu D, Predescu S, Petrache I.

Am J Physiol Lung Cell Mol Physiol. 2015 Aug 15;309(4):L425-34. doi: 10.1152/ajplung.00376.2014. Epub 2015 Jun 19.

7.

Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance.

McCaslin CA, Petrusca DN, Poirier C, Serban KA, Anderson GG, Petrache I.

J Cyst Fibros. 2015 Jan;14(1):70-77. doi: 10.1016/j.jcf.2014.06.009. Epub 2014 Jul 12.

8.

Active trafficking of alpha 1 antitrypsin across the lung endothelium.

Lockett AD, Brown MB, Santos-Falcon N, Rush NI, Oueini H, Oberle AJ, Bolanis E, Fragoso MA, Petrusca DN, Serban KA, Schweitzer KS, Presson RG Jr, Campos M, Petrache I.

PLoS One. 2014 Apr 17;9(4):e93979. doi: 10.1371/journal.pone.0093979. eCollection 2014.

9.

Effects of lipid interactions on model vesicle engulfment by alveolar macrophages.

Justice MJ, Petrusca DN, Rogozea AL, Williams JA, Schweitzer KS, Petrache I, Wassall SR, Petrache HI.

Biophys J. 2014 Feb 4;106(3):598-609. doi: 10.1016/j.bpj.2013.12.036.

10.

Smoking exposure induces human lung endothelial cell adaptation to apoptotic stress.

Petrusca DN, Van Demark M, Gu Y, Justice MJ, Rogozea A, Hubbard WC, Petrache I.

Am J Respir Cell Mol Biol. 2014 Mar;50(3):513-25. doi: 10.1165/rcmb.2013-0023OC.

11.

The involvement of sphingolipids in chronic obstructive pulmonary diseases.

Petrache I, Petrusca DN.

Handb Exp Pharmacol. 2013;(216):247-64. doi: 10.1007/978-3-7091-1511-4_12. Review.

PMID:
23563660
12.

Involvement of ceramide in cell death responses in the pulmonary circulation.

Petrache I, Petrusca DN, Bowler RP, Kamocki K.

Proc Am Thorac Soc. 2011 Nov;8(6):492-6. doi: 10.1513/pats.201104-034MW. Review.

13.

Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages.

Petrusca DN, Gu Y, Adamowicz JJ, Rush NI, Hubbard WC, Smith PA, Berdyshev EV, Birukov KG, Lee CH, Tuder RM, Twigg HL 3rd, Vandivier RW, Petrache I.

J Biol Chem. 2010 Dec 17;285(51):40322-32. doi: 10.1074/jbc.M110.137604. Epub 2010 Oct 18.

14.

Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance.

Bryant L, Doyle T, Chen Z, Cuzzocrea S, Masini E, Vinci MC, Esposito E, Mazzon E, Petrusca DN, Petrache I, Salvemini D.

Neurosci Lett. 2009 Sep 29;463(1):49-53. doi: 10.1016/j.neulet.2009.07.051. Epub 2009 Jul 23.

15.

Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium.

Sohrab S, Petrusca DN, Lockett AD, Schweitzer KS, Rush NI, Gu Y, Kamocki K, Garrison J, Petrache I.

FASEB J. 2009 Sep;23(9):3149-58. doi: 10.1096/fj.09-129304. Epub 2009 May 7.

16.

Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation.

Ndengele MM, Cuzzocrea S, Masini E, Vinci MC, Esposito E, Muscoli C, Petrusca DN, Mollace V, Mazzon E, Li D, Petrache I, Matuschak GM, Salvemini D.

J Pharmacol Exp Ther. 2009 Apr;329(1):64-75. doi: 10.1124/jpet.108.146290. Epub 2008 Nov 25.

17.

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.

Cao L, Petrusca DN, Satpathy M, Nakshatri H, Petrache I, Matei D.

Carcinogenesis. 2008 Oct;29(10):1893-900. doi: 10.1093/carcin/bgn158. Epub 2008 Jul 29.

18.

Apoptotic sphingolipid signaling by ceramides in lung endothelial cells.

Medler TR, Petrusca DN, Lee PJ, Hubbard WC, Berdyshev EV, Skirball J, Kamocki K, Schuchman E, Tuder RM, Petrache I.

Am J Respir Cell Mol Biol. 2008 Jun;38(6):639-46. doi: 10.1165/rcmb.2007-0274OC. Epub 2008 Jan 10.

19.

Cell cycle regulatory factors in juxta-tumoral renal parenchyma.

Petruşcă DN, Petrescu A, Vrabie C, Niculescu L, Jinga V, Diaconu C, Braşoveanu L.

Rom J Morphol Embryol. 2005;46(2):117-22.

20.

Optimization of immunochemical methods for intracellular protein detection.

Petruşcă DN, Popa OM, Gavrilă L, Sulică A.

Rom J Virol. 1999 Jan-Dec;50(1-4):33-41.

PMID:
11601378
21.

Differential down-regulation of CD95 or CD95L in chronically HIV-infected cells of monocytic or lymphocytic origin: cellular studies and molecular analysis by quantitative competitive RT-PCR.

Pinti M, Pedrazzi J, Benatti F, Sorrentino V, Nuzzo C, Cavazzuti V, Biswas P, Petrusca DN, Mussini C, De Rienzo B, Cossarizza A.

FEBS Lett. 1999 Sep 17;458(2):209-14.

Supplemental Content

Loading ...
Support Center